Baidu
map
WORLD J DIABETES 润色咨询

World Journal of Diabetes

出版年份:暂无数据 年文章数:1013 投稿命中率: 开通期刊会员,数据随心看

出版周期:暂无数据 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2218001, encodeId=4ace2218001b4, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:糖尿病<br>经验分享:还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5645498815, createdName=ms7000000459014295, createdTime=Thu Aug 01 16:36:29 CST 2024, time=2024-08-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2116129, encodeId=b76b211612978, content=偏重的研究方向:糖尿病<br>经验分享:糖尿病相关即可, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Thu Feb 23 16:00:48 CST 2023, time=2023-02-23, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2192986, encodeId=0a2a21929860f, content=偏重的研究方向:糖尿病并发症<br>经验分享:糖尿能结合肺癌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Wed Mar 13 16:42:56 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2121583, encodeId=f43b21215838b, content=肺癌结合糖尿病,糖尿病与心血管 都可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Fri Mar 24 14:41:15 CST 2023, time=2023-03-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2140297, encodeId=f86c214029eda, content=点我头像,接收保证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Thu Jun 01 11:10:46 CST 2023, time=2023-06-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2136244, encodeId=51652136244c1, content=糖尿病肾病, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1fc75545988, createdName=dljjy1953, createdTime=Wed May 17 00:58:36 CST 2023, time=2023-05-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=972650, encodeId=5dcb9e2650f2, content=投稿很麻烦,要各种材料,还要每个作者的ORCID码,字体、格式都很特殊,包括应用文献的格式,第一个作者要加粗,需要自己手动一个一个改,最后因为太复杂,放弃投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=07ac5502075, createdName=ms5000001436647887, createdTime=Thu Jun 10 21:23:21 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2024-08-01 ms7000000459014295 来自北京

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向:糖尿病
    经验分享:还没投

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2218001, encodeId=4ace2218001b4, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:糖尿病<br>经验分享:还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5645498815, createdName=ms7000000459014295, createdTime=Thu Aug 01 16:36:29 CST 2024, time=2024-08-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2116129, encodeId=b76b211612978, content=偏重的研究方向:糖尿病<br>经验分享:糖尿病相关即可, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Thu Feb 23 16:00:48 CST 2023, time=2023-02-23, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2192986, encodeId=0a2a21929860f, content=偏重的研究方向:糖尿病并发症<br>经验分享:糖尿能结合肺癌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Wed Mar 13 16:42:56 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2121583, encodeId=f43b21215838b, content=肺癌结合糖尿病,糖尿病与心血管 都可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Fri Mar 24 14:41:15 CST 2023, time=2023-03-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2140297, encodeId=f86c214029eda, content=点我头像,接收保证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Thu Jun 01 11:10:46 CST 2023, time=2023-06-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2136244, encodeId=51652136244c1, content=糖尿病肾病, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1fc75545988, createdName=dljjy1953, createdTime=Wed May 17 00:58:36 CST 2023, time=2023-05-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=972650, encodeId=5dcb9e2650f2, content=投稿很麻烦,要各种材料,还要每个作者的ORCID码,字体、格式都很特殊,包括应用文献的格式,第一个作者要加粗,需要自己手动一个一个改,最后因为太复杂,放弃投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=07ac5502075, createdName=ms5000001436647887, createdTime=Thu Jun 10 21:23:21 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2023-02-23 科研小帮 来自广西

    偏重的研究方向:糖尿病
    经验分享:糖尿病相关即可

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2218001, encodeId=4ace2218001b4, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:糖尿病<br>经验分享:还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5645498815, createdName=ms7000000459014295, createdTime=Thu Aug 01 16:36:29 CST 2024, time=2024-08-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2116129, encodeId=b76b211612978, content=偏重的研究方向:糖尿病<br>经验分享:糖尿病相关即可, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Thu Feb 23 16:00:48 CST 2023, time=2023-02-23, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2192986, encodeId=0a2a21929860f, content=偏重的研究方向:糖尿病并发症<br>经验分享:糖尿能结合肺癌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Wed Mar 13 16:42:56 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2121583, encodeId=f43b21215838b, content=肺癌结合糖尿病,糖尿病与心血管 都可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Fri Mar 24 14:41:15 CST 2023, time=2023-03-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2140297, encodeId=f86c214029eda, content=点我头像,接收保证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Thu Jun 01 11:10:46 CST 2023, time=2023-06-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2136244, encodeId=51652136244c1, content=糖尿病肾病, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1fc75545988, createdName=dljjy1953, createdTime=Wed May 17 00:58:36 CST 2023, time=2023-05-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=972650, encodeId=5dcb9e2650f2, content=投稿很麻烦,要各种材料,还要每个作者的ORCID码,字体、格式都很特殊,包括应用文献的格式,第一个作者要加粗,需要自己手动一个一个改,最后因为太复杂,放弃投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=07ac5502075, createdName=ms5000001436647887, createdTime=Thu Jun 10 21:23:21 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2024-03-13 ms4000000361701675 来自广西

    偏重的研究方向:糖尿病并发症
    经验分享:糖尿能结合肺癌

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2218001, encodeId=4ace2218001b4, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:糖尿病<br>经验分享:还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5645498815, createdName=ms7000000459014295, createdTime=Thu Aug 01 16:36:29 CST 2024, time=2024-08-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2116129, encodeId=b76b211612978, content=偏重的研究方向:糖尿病<br>经验分享:糖尿病相关即可, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Thu Feb 23 16:00:48 CST 2023, time=2023-02-23, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2192986, encodeId=0a2a21929860f, content=偏重的研究方向:糖尿病并发症<br>经验分享:糖尿能结合肺癌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Wed Mar 13 16:42:56 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2121583, encodeId=f43b21215838b, content=肺癌结合糖尿病,糖尿病与心血管 都可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Fri Mar 24 14:41:15 CST 2023, time=2023-03-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2140297, encodeId=f86c214029eda, content=点我头像,接收保证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Thu Jun 01 11:10:46 CST 2023, time=2023-06-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2136244, encodeId=51652136244c1, content=糖尿病肾病, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1fc75545988, createdName=dljjy1953, createdTime=Wed May 17 00:58:36 CST 2023, time=2023-05-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=972650, encodeId=5dcb9e2650f2, content=投稿很麻烦,要各种材料,还要每个作者的ORCID码,字体、格式都很特殊,包括应用文献的格式,第一个作者要加粗,需要自己手动一个一个改,最后因为太复杂,放弃投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=07ac5502075, createdName=ms5000001436647887, createdTime=Thu Jun 10 21:23:21 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2023-03-24 ms7000000487939564 来自广西

    肺癌结合糖尿病,糖尿病与心血管 都可以

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2218001, encodeId=4ace2218001b4, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:糖尿病<br>经验分享:还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5645498815, createdName=ms7000000459014295, createdTime=Thu Aug 01 16:36:29 CST 2024, time=2024-08-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2116129, encodeId=b76b211612978, content=偏重的研究方向:糖尿病<br>经验分享:糖尿病相关即可, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Thu Feb 23 16:00:48 CST 2023, time=2023-02-23, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2192986, encodeId=0a2a21929860f, content=偏重的研究方向:糖尿病并发症<br>经验分享:糖尿能结合肺癌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Wed Mar 13 16:42:56 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2121583, encodeId=f43b21215838b, content=肺癌结合糖尿病,糖尿病与心血管 都可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Fri Mar 24 14:41:15 CST 2023, time=2023-03-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2140297, encodeId=f86c214029eda, content=点我头像,接收保证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Thu Jun 01 11:10:46 CST 2023, time=2023-06-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2136244, encodeId=51652136244c1, content=糖尿病肾病, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1fc75545988, createdName=dljjy1953, createdTime=Wed May 17 00:58:36 CST 2023, time=2023-05-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=972650, encodeId=5dcb9e2650f2, content=投稿很麻烦,要各种材料,还要每个作者的ORCID码,字体、格式都很特殊,包括应用文献的格式,第一个作者要加粗,需要自己手动一个一个改,最后因为太复杂,放弃投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=07ac5502075, createdName=ms5000001436647887, createdTime=Thu Jun 10 21:23:21 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2023-06-01 ms7000000487939564 来自广西

    点我头像,接收保证

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2218001, encodeId=4ace2218001b4, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:糖尿病<br>经验分享:还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5645498815, createdName=ms7000000459014295, createdTime=Thu Aug 01 16:36:29 CST 2024, time=2024-08-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2116129, encodeId=b76b211612978, content=偏重的研究方向:糖尿病<br>经验分享:糖尿病相关即可, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Thu Feb 23 16:00:48 CST 2023, time=2023-02-23, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2192986, encodeId=0a2a21929860f, content=偏重的研究方向:糖尿病并发症<br>经验分享:糖尿能结合肺癌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Wed Mar 13 16:42:56 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2121583, encodeId=f43b21215838b, content=肺癌结合糖尿病,糖尿病与心血管 都可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Fri Mar 24 14:41:15 CST 2023, time=2023-03-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2140297, encodeId=f86c214029eda, content=点我头像,接收保证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Thu Jun 01 11:10:46 CST 2023, time=2023-06-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2136244, encodeId=51652136244c1, content=糖尿病肾病, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1fc75545988, createdName=dljjy1953, createdTime=Wed May 17 00:58:36 CST 2023, time=2023-05-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=972650, encodeId=5dcb9e2650f2, content=投稿很麻烦,要各种材料,还要每个作者的ORCID码,字体、格式都很特殊,包括应用文献的格式,第一个作者要加粗,需要自己手动一个一个改,最后因为太复杂,放弃投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=07ac5502075, createdName=ms5000001436647887, createdTime=Thu Jun 10 21:23:21 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2023-05-17 dljjy1953 来自浙江省

    糖尿病肾病

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2218001, encodeId=4ace2218001b4, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向:糖尿病<br>经验分享:还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e5645498815, createdName=ms7000000459014295, createdTime=Thu Aug 01 16:36:29 CST 2024, time=2024-08-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2116129, encodeId=b76b211612978, content=偏重的研究方向:糖尿病<br>经验分享:糖尿病相关即可, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230131/26b2bd8fee4a4f8b82ae4707672c735e/901f236ce8ca4e9c8714b0c839e0f0fd.jpg, createdBy=1e8f8124292, createdName=科研小帮, createdTime=Thu Feb 23 16:00:48 CST 2023, time=2023-02-23, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2192986, encodeId=0a2a21929860f, content=偏重的研究方向:糖尿病并发症<br>经验分享:糖尿能结合肺癌, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231027/c966878f146e4e0dbf8418b9b86fbb57/c2d7036599894bf0b8f0dd9085325554.jpg, createdBy=54379018170, createdName=ms4000000361701675, createdTime=Wed Mar 13 16:42:56 CST 2024, time=2024-03-13, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2121583, encodeId=f43b21215838b, content=肺癌结合糖尿病,糖尿病与心血管 都可以, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Fri Mar 24 14:41:15 CST 2023, time=2023-03-24, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2140297, encodeId=f86c214029eda, content=点我头像,接收保证, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Thu Jun 01 11:10:46 CST 2023, time=2023-06-01, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2136244, encodeId=51652136244c1, content=糖尿病肾病, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1fc75545988, createdName=dljjy1953, createdTime=Wed May 17 00:58:36 CST 2023, time=2023-05-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=972650, encodeId=5dcb9e2650f2, content=投稿很麻烦,要各种材料,还要每个作者的ORCID码,字体、格式都很特殊,包括应用文献的格式,第一个作者要加粗,需要自己手动一个一个改,最后因为太复杂,放弃投稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=07ac5502075, createdName=ms5000001436647887, createdTime=Thu Jun 10 21:23:21 CST 2021, time=2021-06-10, status=1, ipAttribution=)]
    2021-06-10 ms5000001436647887

    投稿很麻烦,要各种材料,还要每个作者的ORCID码,字体、格式都很特殊,包括应用文献的格式,第一个作者要加粗,需要自己手动一个一个改,最后因为太复杂,放弃投稿

    0

共16条页码: 1/2页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map